TY - JOUR
T1 - The pattern of substance use disorder in the United Arab Emirates in 2015
T2 - Results of a National Rehabilitation Centre cohort study
AU - Alblooshi, Hiba
AU - Hulse, Gary K.
AU - El Kashef, Ahmed
AU - Al Hashmi, Hanan
AU - Shawky, Mansour
AU - Al Ghaferi, Hamad
AU - Al Safar, Habiba
AU - Tay, Guan K.
N1 - Funding Information:
We acknowledge the support and assistance from the clinicians and staff at the UAE National Rehabilitation Centre (NRC) for providing some of the data required for this study. Miss Alblooshi is a doctoral student at the Centre for Forensic Science, University of Western Australia. She acknowledges a scholarship from the UAE Higher Ministry of Education and Scientific Research that has allowed her to pursue her studies in Australia.
Publisher Copyright:
© 2016 Alblooshi et al.
PY - 2016/5/13
Y1 - 2016/5/13
N2 - Background: Substance use disorder (SUD) is a global problem with no boundaries, which also afflicts individuals from countries of the Arabian Peninsula. Data from this region is limited. In an effort to develop targeted prevention and intervention initiatives in the United Arab Emirates (UAE), it was necessary to identify the nature of substance use by describing the characteristics of those using different substances. Consequently, this study in the UAE was conceived to describe the pattern of SUD in a first-ever cohort that was systematically recruited from the country's National Rehabilitation Centre (NRC) in Abu Dhabi. Methods: Two hundred and fifty male patients were recruited from the NRC. Information on substance use was collected using a questionnaire that was completed at an interview with patients who consented to participate. The questionnaire was based on information that the study was designed to capture. It was reviewed by members of institutional ethics committees and approved prior to use. Two hundred and fifty male subjects from the Emirates Family Registry (EFR) were used as a comparison group. Results: In the cohort studied, SUD correlated with smoking and marital status. Poly-substance users formed the majority of the cohort (84.4 %) with various combinations of substances identified across different age groups. Opioid and alcohol were the most common substances used. The use of pharmaceutical opioids, primarily Tramadol (67.2 % of opioid users), was higher among the youngest age group studied (<30 years old), while older opioid users (≥30 years old) commonly used illicit opioids (Heroin). The use of prescribed medication for non-medical use also included Pregabalin (mean of 8.3 capsules ± 0.5 per day), Procyclidin (6.1 tablets + 0.6 per day) and Carisoprodol (4.2 tablets ± 0.4 per day) and was again highest in the age group below 30 years. Conclusion: This 2015 study highlights the importance of examining the pattern of poly-substance use in a population in order to develop targeted prevention programs to arrest the prevailing trends. It has drawn attention to the rise in use of prescription medication in the UAE, in particular among younger patients (<30 years), and continuing use of illicit opioid amongst males above 30 years. Specific prevention and intervention strategies, targeting differences between these distinct demographic profiles will capture a large subset of sufferers.
AB - Background: Substance use disorder (SUD) is a global problem with no boundaries, which also afflicts individuals from countries of the Arabian Peninsula. Data from this region is limited. In an effort to develop targeted prevention and intervention initiatives in the United Arab Emirates (UAE), it was necessary to identify the nature of substance use by describing the characteristics of those using different substances. Consequently, this study in the UAE was conceived to describe the pattern of SUD in a first-ever cohort that was systematically recruited from the country's National Rehabilitation Centre (NRC) in Abu Dhabi. Methods: Two hundred and fifty male patients were recruited from the NRC. Information on substance use was collected using a questionnaire that was completed at an interview with patients who consented to participate. The questionnaire was based on information that the study was designed to capture. It was reviewed by members of institutional ethics committees and approved prior to use. Two hundred and fifty male subjects from the Emirates Family Registry (EFR) were used as a comparison group. Results: In the cohort studied, SUD correlated with smoking and marital status. Poly-substance users formed the majority of the cohort (84.4 %) with various combinations of substances identified across different age groups. Opioid and alcohol were the most common substances used. The use of pharmaceutical opioids, primarily Tramadol (67.2 % of opioid users), was higher among the youngest age group studied (<30 years old), while older opioid users (≥30 years old) commonly used illicit opioids (Heroin). The use of prescribed medication for non-medical use also included Pregabalin (mean of 8.3 capsules ± 0.5 per day), Procyclidin (6.1 tablets + 0.6 per day) and Carisoprodol (4.2 tablets ± 0.4 per day) and was again highest in the age group below 30 years. Conclusion: This 2015 study highlights the importance of examining the pattern of poly-substance use in a population in order to develop targeted prevention programs to arrest the prevailing trends. It has drawn attention to the rise in use of prescription medication in the UAE, in particular among younger patients (<30 years), and continuing use of illicit opioid amongst males above 30 years. Specific prevention and intervention strategies, targeting differences between these distinct demographic profiles will capture a large subset of sufferers.
KW - Alcohol drinking
KW - Opioid-related disorders
KW - Prescription medication use
KW - Substance-related disorders
KW - United Arab Emirates
UR - http://www.scopus.com/inward/record.url?scp=84971273022&partnerID=8YFLogxK
U2 - 10.1186/s13011-016-0062-5
DO - 10.1186/s13011-016-0062-5
M3 - Article
C2 - 27177422
AN - SCOPUS:84971273022
SN - 1747-597X
VL - 11
JO - Substance Abuse: Treatment, Prevention, and Policy
JF - Substance Abuse: Treatment, Prevention, and Policy
IS - 1
M1 - 19
ER -